Blog

Big Yellow Group PLC (LSE:BYG) has received planning approval for a 55,000 sq ft storage centre in Leamington Spa, scheduled to open in summer 2027. The project forms part of the company’s broader expansion strategy and is expected to generate an 8.5% net operating income return once stabilised, strengthening both its market position and operational capacity.

The company’s outlook is supported by strong financial results and strategic corporate moves, including growth initiatives and executive incentive programmes. Valuation metrics remain attractive, with a low P/E ratio and a high dividend yield. Technical indicators point to a neutral trend, showing no strong bullish or bearish bias. The lack of earnings call information has no material impact on the overall view.

About Big Yellow Group

Big Yellow Group PLC is a leading UK self-storage provider, specialising in the development and operation of large-scale storage facilities. Serving both private individuals and businesses, the company has built a strong brand around secure, flexible, and accessible storage solutions.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Bellway p.l.c. (LSE:BMY) has posted robust results for the financial year ended 31 July 2025, recording a 14.3% increase in housing completions and a 17% rise in housing revenue. The average selling price reached £316,000, while operating margin improved to nearly 11%. The company’s forward order book expanded to 5,307 homes, supported by a substantial land bank and a disciplined approach to acquisitions. Looking ahead to FY26, Bellway aims to raise output to around 9,200 homes. Despite ongoing market pressures, the company remains confident in its capacity to drive sustainable growth and enhance shareholder value, aided by recent UK government planning reforms.

Bellway’s market outlook reflects mixed financial signals—its strong balance sheet contrasts with weaker income and cash flow metrics. Technical analysis points to bearish momentum, weighing on sentiment, though strategic insights from recent earnings updates and corporate announcements provide a modest boost to the overall view.

About Bellway

Bellway p.l.c. is a UK-based homebuilder specialising in the construction and sale of residential properties. Known for delivering high-quality homes, the company leverages its significant land holdings and commitment to capital efficiency to fuel growth and deliver long-term returns to shareholders.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

IXICO plc (LSE:IXI) has landed two major agreements worth roughly £1.3 million to deliver neuroimaging services for clinical trials targeting Alzheimer’s Disease and Friedreich’s Ataxia. The deals align with the company’s strategy to broaden its global footprint and strengthen its position as a leader in neurodegenerative disease research. The first contract covers the management and analysis of imaging data for a Phase 1 Alzheimer’s study over three and a half years, while the second will support a Phase 1b Friedreich’s Ataxia trial across a six-year period. These milestones underscore IXICO’s innovative platform and its role as a trusted voice in the neuroscience community.

IXICO’s market outlook remains shaped by financial constraints and technical analysis trends. While technical signals point to positive momentum, challenges in underlying financial performance and valuation persist. Nonetheless, recent corporate developments indicate potential growth opportunities, contributing to an overall constructive outlook.

About IXICO plc

IXICO plc is a global specialist in neuroscience imaging and biomarker analytics, leveraging its AI-powered platform to accelerate drug development for neurological conditions. With two decades of experience as an Imaging Contract Research Organisation (iCRO), IXICO partners with pharmaceutical companies, biotech firms, and non-profits worldwide. The company supports numerous clinical trials and processes extensive imaging datasets to aid in the development of treatments for diseases including Alzheimer’s, Huntington’s, and Parkinson’s.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Block Energy plc (LSE:BLOE) has shared an update on its diverse project portfolio, detailing advances in farmouts, Carbon Capture and Storage (CCS), drilling initiatives, and new business opportunities. Negotiations for farmouts on Projects III and IV are progressing well, supported by strong technical and commercial alignment. The CCS pilot—scheduled to begin injection operations this quarter—has the potential to establish Block as a regional leader in mineralisation-based CO₂ storage. In Project I, the company plans to deploy a cost-efficient “slim hole” drilling method, which could open the door to additional low-cost drilling prospects. Block Energy continues to prioritise capital-efficient expansion across both its Georgian base and international markets.

About Block Energy plc

Block Energy plc is an AIM-listed independent oil and gas producer and developer focused on Georgia. Holding interests in seven Production Sharing Contracts in central Georgia, the company is committed to unlocking the region’s energy potential. Its operations follow a four-project strategy aimed at boosting output, redeveloping existing fields, discovering new reserves, and harnessing untapped gas resources, with a strategic eye toward supplying the EU market.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Spirax Group (LSE:SPX) has posted its half-year 2025 results, recording a 3% rise in organic revenue even as global economic pressures persist. The company reaffirmed its full-year outlook, supported by strong order pipelines and robust demand across priority markets. While statutory profit margins were weighed down by restructuring expenses and currency fluctuations, adjusted operating profit still rose organically by 7%. Spirax is maintaining its focus on efficiency gains and targeted investments in digital capabilities and decarbonisation projects to secure sustainable, long-term growth.

Spirax Sarco Engineering’s outlook remains positive, underpinned by solid financial results and favourable corporate developments. Short-term caution is suggested by certain technical indicators, while valuation levels signal moderate investment appeal. The lack of recent earnings call commentary, however, limits visibility into forward guidance.

About Spirax Sarco Engineering

Spirax Group plc is a leading industrial technology company specialising in thermal energy management and fluid control solutions designed to improve safety and efficiency in critical operations. The group is advancing industrial decarbonisation through innovative solutions and operates three main divisions: Steam Thermal Solutions, Electric Thermal Solutions, and Watson-Marlow Fluid Technology Solutions. Its technologies serve a broad spectrum of sectors, including food processing, healthcare, aerospace, and semiconductor manufacturing.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cambridge Cognition Holdings (LSE:COG) has unveiled a proprietary speaker recognition technology designed to prevent duplicate enrolment of participants in clinical trials—a major challenge that can compromise data quality and undermine study validity. The innovation forms part of the company’s AI-driven, voice-enabled data quality management suite. It has already secured early commercial agreements and is scheduled for rollout with a leading pharmaceutical partner in Q4 2025, underscoring Cambridge Cognition’s focus on improving the reliability and efficiency of clinical research.

While the company is making strategic strides, its overall outlook is tempered by ongoing financial headwinds, including falling revenues and persistent losses. Weak technical signals and unfavourable valuation metrics further weigh on performance expectations. Nevertheless, progress on strategic initiatives and successful clinical collaborations provide a degree of support, partially offsetting the financial and technical challenges.

About Cambridge Cognition Holdings

Cambridge Cognition is a specialist in brain health software, delivering digital health solutions to advance research, diagnosis, and treatment in cognitive science. Its work spans pharmaceutical clinical trials, academic research into central nervous system disorders, healthcare-based cognitive assessments, and consumer-focused brain health and wellness tools.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Atalaya Mining (LSE:ATYM) has delivered its strongest-ever quarterly and half-year results for Q2 and H1 2025, reporting sharp gains in EBITDA and net cash. These improvements stem from higher copper grades and greater operational efficiency. The miner has upgraded its production and cost guidance, announced an interim dividend, and is progressing with strategic growth initiatives aimed at reinforcing its competitive position and generating long-term value for stakeholders.

The company’s high overall score is primarily underpinned by robust technical metrics and favorable corporate developments. Its strong financial showing further supports this view, although fluctuations in revenue and ongoing capital investments remain potential headwinds. While the current valuation is considered reasonable, its impact on the outlook is positive but more limited.

About Atalaya Mining

Atalaya Mining is a copper-focused producer with key operations in Spain. The company is advancing several development projects, including San Dionisio, Masa Valverde, and Touro, with the aim of expanding copper output and improving cost efficiency.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Last week, the US imposed reciprocal tariffs — ranging from 10% to 41% — on imports from 69 countries and the European Union.  In addition, Donald Trump announced plans to introduce a 100% tariff on imported chips and semiconductors, and an even higher percentage on all pharmaceutical imports.

Now, if exporters were the ones paying, the markets would have no problem. But these are import tariffs, meaning higher costs will fall on households. In fact, consumers already bear about 22% of the expenses related to tariffs in June. Even so, the markets do not seem too concerned about that.

Neither the S&P 500 nor the Nasdaq reacted much to last week’s tariff announcement. One possible reason could be optimism about the president’s so-called TACO initiative, coupled with hopes that, despite everything, the Federal Reserve will continue to lower rates at its September meeting.

However, there could be another long-standing factor supporting the market: corporate buybacks. Since January this year, companies have announced buyback programs worth more than $980 billion, the highest figure since 1982, and this is expected to exceed $1.1 trillion by the end of the year.

The earnings season has also been encouraging. According to FactSet, 90% of S&P 500 companies have reported their Q2 results. Of those, 81% exceeded EPS estimates, above the five-year average of 78% and the ten-year average of 75%. More importantly, companies do not expect a disaster in the near future.

S&P 500 to 7,000?

While analysts continue to find reasons why the market should fall (and, to be fair, there are many), stocks keep surging. The problem is that, without healthy pullbacks, it is difficult to consider this a sustainable trend. Thus, the fall could be much more pronounced when the bad news finally arrives.
The first test will be the CPI report on Tuesday and the PPI report on Thursday. On Friday, Trump will meet with Putin. However, the most anticipated event this month is probably Nvidia’s quarterly earnings report on August 27. If the results disappoint, as in the case of AMD, it could trigger a sell-off across the US market.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Tesla (NASDAQ:TSLA), led by Elon Musk, has formally applied to the UK’s energy regulator, Ofgem, for a license to become an electricity supplier across Britain. The application, submitted at the end of last month, was authorized by Andrew Payne, who oversees Tesla’s energy business in Europe.

If granted, this license would position Tesla to challenge established energy providers like British Gas, Octopus Energy, and E.ON by supplying electricity to residential and commercial customers throughout England, Scotland, and Wales. The regulatory review could take up to nine months before a decision is made.

Tesla plans to launch this venture under the “Tesla Electric” brand, which has been operating in Texas since 2022. There, the service provides affordable electric vehicle charging and compensates customers who feed surplus energy back into the grid.

The company aims to bundle its electricity services with its existing product lineup in the UK — including electric cars and home battery storage — to help consumers lower their electricity costs while enhancing energy efficiency. Tesla’s UK footprint already includes over 250,000 vehicles sold and thousands of energy storage units installed.

Meanwhile, Tesla’s vehicle sales across Europe are on a downward trend. In July, UK sales dropped nearly 60%, with only 987 units sold compared to 2,462 during the same month last year. Germany saw a 55% decline with 1,110 cars sold.

Across Europe’s top ten markets, Tesla’s sales shrank by 45% last month. The company is facing intense competition from Chinese automakers such as BYD, as well as some reputational challenges tied to Elon Musk’s political views and his association with former U.S. President Donald Trump.

Nonetheless, Tesla is leveraging its strong brand presence and loyal customer base in the UK to break into the energy sector. If successful in securing the license, Tesla could begin operations as soon as next year.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.